Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;1(1):65-68.
doi: 10.3892/etm_00000011. Epub 2010 Jan 1.

Evaluation of the chemosensitivity of primary cultured malignant melanoma cells using the collagen gel droplet-embedded culture drug sensitivity test

Affiliations

Evaluation of the chemosensitivity of primary cultured malignant melanoma cells using the collagen gel droplet-embedded culture drug sensitivity test

Miki Tanioka et al. Exp Ther Med. 2010 Jan.

Abstract

Malignant melanoma usually shows resistance to a standard chemotherapy regimen. A useful in vitro method to evaluate individual chemosensitivity is required to select effective anti-cancer drugs. This study aimed to establish in vitro tumor response testing for malignant melanoma. We determined the chemosensitivity of primary cultured melanoma cells using the collagen gel droplet-embedded culture drug sensitivity test (CD-DST). Nineteen tests were carried out for 15 cases of malignant melanoma. Primary cultured melanoma cells in collagen gel droplets were exposed to anti-cancer drugs, including cisplatin, adriamycin, dacarbazine, nimustine and vincristine. After a 7-day incubation in a serum-free medium, living melanoma cells in a collagen droplet were detected by image analysis after staining with Neutral red reagent. In vitro drug exposure conditions were determined to reproduce the value of the plasma area under the time-drug concentration curve in vivo. The rate of evaluation of the primary culture of melanoma cells was 78.9% (15/19 tests). The chemosensitivity of cisplatin, adriamycin, dacarbazine, nimustine and vincristine was 15, 62, 0, 0 and 62%, respectively. Dacarbazine was not suitable for CD-DST due to its prodrug characteristics. The CD-DST method was able to evaluate the chemosensitivity of malignant melanoma to anti-cancer drugs in vitro. This method can also be applied to estimate the efficacy of newly developed anti-cancer drugs in vitro.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Dose response curve of B16 cells against dacarbazine at various concentrations in the CD-DST. (B) Dose response curve of B16 cells against nimustine for various incubation times in the CD-DST.
Figure 1.
Figure 1.
(A) Dose response curve of B16 cells against dacarbazine at various concentrations in the CD-DST. (B) Dose response curve of B16 cells against nimustine for various incubation times in the CD-DST.

Similar articles

References

    1. Buzaid AC, Bedikian A, Houghton AN. Cutaneous Melanoma. 3rd edition. Quality Medical Publishing; St. Louis: 1998. pp. 405–418.
    1. Balch CM, Reintgen DS, Kirkwood JN, et al. Cancer: Principles and Practice of Oncology. 5th edition. Lippincot-Raven Publishers; Philadelphia: 1997. pp. 1947–1994.
    1. Kobayashi H, Tanisaka K, Doi O, et al. An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. Int J Oncol. 1997;11:449–455. - PubMed
    1. Mitsuhashi Y, Sugiyama Y, Ozawa S, et al. Prediction of ANCU plasma concentration-time profiles in humans by animal scale up. Cancer Chemother Pharmacol. 1990;27:20–26. - PubMed
    1. Breithaupt H, Dammann A, Aigner K. Pharmacokinetics of dacarbazine (DITC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules. Cancer Chemother Pharmacol. 1982;9:103–109. - PubMed

LinkOut - more resources